Small children and pregnant women may be underdosed with widely used antimalarial drug

Antimalarial resistance deserves higher priority in global AMR strategy

15 October 2025

In a new commentary for BMJ Global Health, University of Oxford researchers argue that antimicrobial resistance (AMR) interventions often ignore morally relevant differences between microbes. They highlight that antimalarial resistance disproportionately affects low- and middle-income countries, particularly children in sub-Saharan Africa, and deserves greater attention in global health research and intervention priorities. The team calls for more equitable resource allocation, policy change, and advocacy to ensure AMR responses are just and inclusive.

FD-TACT malaria treatment trial launches patient recruitment in Rwanda

MORU Community Advisory Boards meet in Bangkok

Joel Tarning awarded RSTMH’s 2025 Chalmers Medal

Simple new method that measures viral clearance means antibody treatments for COVID and ‘flu can be quickly assessed for effectiveness, say MORU researchers

15 emerging Asian global health researchers selected to join MODRA